Pharmacies began to refuse to sell powerful psychotropic drugs, since working with them became unprofitable due to strict control and price regulation. Pharmaceutical market expert and economist Pavel Lisovsky shared information in a conversation with Radio 1, warning about the possible disappearance of these drugs from the shelves.

According to the expert, obtaining approval for the sale of potent psychotropic drugs is now difficult due to the high costs of organizing supplies and sales, and the profitability in this area is low.

“The turnover of these drugs is small, and the costs of maintaining them are high. In addition, the state strictly regulates the markup, which depends on the region,” the economist noted.

Lisovsky addedthat the decision on whether to sell these drugs is now made by the pharmacy chain itself.

“This problem can be solved either through government pharmacies or through interested parties. It is not necessary for every pharmacy to sell these drugs – this is irrational if there is not enough turnover. However, there should be a number of pharmacies providing access to these drugs. For example, five pharmacies in a city with a population of one million people could solve this problem,” the interlocutor noted.